top of page

Drug Development in NMIBC from Scientific, Regulatory, Clinician, and Patient Perspectives (2021)

AUA
3/4/21, 6:00 PM
America/New York GMT -4 summer

Description

 

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Yair Lotan, John Sfakianos

Welcome, Opening Remarks, Bladder Cancer Advocacy Network (BCAN) Patient Panel, PANEL: Clinical Development of Therapies for NMIBC: What is Success?, Discussion, Q&A, SESSION ONE: Drug Development for BCG-Naïve NMIBC, Model Systems to Facilitate Development of Therapies for NMIBC, What Novel Therapies Can Compete (or Combine) with BCG in BCG-Naïve NMIBC?, Regulatory Considerations in the BCG-Naïve NMIBC Setting, Discussion, Q&A

Inglês

Description

Speakers

Matthew Galsky, Yair Lotan, David McConkey, Aria F. Olumi, Carolyn J.M. Best, Seth Lerner, Noah Hahn, Brian Baumann, Elaine Chang, Phillip Abbosh, Robert Svatek, Chana Weinstock

Speakers
Link to Event
Banner
Registro
bottom of page